Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Filed Chapter 11
NephroGenex, Inc. (NRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
05/24/2017 8-K Quarterly results
05/18/2017 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Case 16-11074-KG Doc 422 Filed 05/10/17 Page 1 of"
05/11/2017 8-K Form 8-K - Current report
04/21/2017 8-K Form 8-K - Current report
04/20/2017 8-K Form 8-K - Current report
03/24/2017 8-K Regulation FD Disclosure, Financial Statements and Exhibits
03/15/2017 8-K Form 8-K - Current report
03/01/2017 8-K Form 8-K - Current report
02/17/2017 8-K Regulation FD Disclosure, Financial Statements and Exhibits
02/16/2017 8-K Form 8-K - Current report
02/14/2017 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/01/2017 8-K Form 8-K - Current report
01/18/2017 8-K Regulation FD Disclosure, Financial Statements and Exhibits
12/20/2016 8-K Regulation FD Disclosure, Financial Statements and Exhibits
12/16/2016 8-K Regulation FD Disclosure, Financial Statements and Exhibits
11/15/2016 8-K Form 8-K - Current report
10/14/2016 8-K Regulation FD Disclosure, Financial Statements and Exhibits
08/23/2016 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "IN THE UNITED STATES BANKRUPTCY COURT"
07/20/2016 8-K Regulation FD Disclosure, Financial Statements and Exhibits
05/19/2016 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
05/13/2016 8-K Investor presentation
Docs: "Corporate Presentation May 2016"
05/04/2016 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
05/02/2016 8-K Filed for Chapter 11
Docs: "NephroGenex, Inc. Commences Voluntary Chapter 11 Proceeding; Seeks To Initiate Sale Process Under Section 363"
04/13/2016 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
04/13/2016 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Consulting Agreement by and between NephroGenex, Inc. and Stone Mgmt. LLC",
"Consulting Agreement by and between NephroGenex, Inc. and Jaikrishna Patel"
04/07/2016 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
03/28/2016 10-K Annual Report for the period ended December 31, 2015
02/12/2016 SC 13G/A Visium Asset Management, LP reports a 7.1% stake in NephroGenex, Inc.
01/20/2016 SC 13G/A BIOSTRATUM Inc reports a 0% stake in NephroGenex, Inc.
12/15/2015 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
12/10/2015 4 Steiner Eugen (Director) has filed a Form 4 on NephroGenex, Inc.
Txns: Granted 76,045 shares @ $0
11/12/2015 4 Legault Pierre (CEO) has filed a Form 4 on NephroGenex, Inc.
Txns: Granted 646,930 shares @ $0
11/12/2015 4 Hamill John (CFO) has filed a Form 4 on NephroGenex, Inc.
11/12/2015 4 Patel Jaikrishna (Chief Medical Officer) has filed a Form 4 on NephroGenex, Inc.
Txns: Granted 97,306 shares @ $0
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy